InnoCare Pharma Limited (HKG:9969)

Marinus Pharmaceuticals Revenue

InnoCare Pharma had revenue of 381.26M CNY in the quarter ending March 31, 2025, with 129.92% growth. This brings the company's revenue in the last twelve months to 1.22B, up 71.32% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.

• Revenue (ttm): 1.22B CNY
• Revenue Growth: +71.32%
• P/S Ratio: 28.51
• Revenue / Employee: 1.12M CNY
• Employees: 1,089
• Market Cap: 37.44B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.01B	270.91M	36.68%
Dec 31, 2023	738.54M	113.13M	18.09%
Dec 31, 2022	625.40M	-417.63M	-40.04%
Dec 31, 2021	1.04B	1.04B	76,368.70%
Dec 31, 2020	1.36M	117.00K	9.38%